VAREX IMAGING

VREX Healthcare Medical Devices

VAREX IMAGING’s revenue for fiscal 2025 (year ended September 2025) was $844.6 million, up 4.14% from fiscal 2024. In the quarter to June 2026, revenue grew 3.69%, EPS grew 117.2%, free cash flow grew 757.1% and total debt fell 5.55%, each against the same quarter a year earlier.

18.41 0.06 −0.32%
Market cap
$784.3M
P/E
34.7×
Fwd P/E
43.4×
Dividend yield
—
F-score
6/9
Altman Z
1.66
Beneish M
−3.13
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
19.68 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.51 0.52 0.57 0.61
P/FCF ratio
0.00 0.00 0.00 27.31
P/Operating CF
20.91 (297.08) (30.25) 64.98
P/B ratio
0.86 0.91 0.99 1.06
EV/Sales
0.79 0.82 0.85 0.86
EV/EBITDA
6.80 7.70 7.32 7.56
EV/FCF
(34.01) (22.89) (54.81) 38.60
Current Ratio
3.38 3.20 3.89 3.43
Net Debt/EBITDA
8.24 12.06 10.66 7.96
Debt/Equity
0.68 0.71 0.75 0.76
Earnings Yield
5.08% (18.76%) (13.99%) (13.71%)
Free Cash Flow Yield
(4.60%) (6.91%) (2.73%) 3.66%
Free Cash Flow per Share
0.29 (0.18) (0.64) 0.06
Book value per Share
12.13 11.62 11.74 11.75
Free Cash Flow
12.00 (7.70) (26.80) 2.30
EV/EBIT
9.52 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates